eZono AG is a German technology provider for multidisciplinary software solutions and ultrasound systems. Established in 2004, eZono is focused on revolutionizing the use of ultrasound in clinical practice. The company's flagship product, the eZono® 4000, offers innovative solutions to address the real-life challenges faced by clinicians when using ultrasound at the point of care. eZono's mission is to empower non-traditional ultrasound users to integrate sonography into their daily work, aiming to improve clinical outcomes, enhance patient satisfaction, and reduce costs. The company's eZono™ 3000 system is specifically designed for regional anesthesia, making sonography a standard tool for anesthetists. This move helps reduce learning efforts and enhances the precision of procedures, contributing to patient comfort and safety. The company received a significant $10.00M Venture Round investment on 03 January 2013 led by MVM Life Science Partners. The investment was crucial for further innovation and expansion. With its focus on medical devices and a commitment to challenging the status quo in ultrasound imaging, eZono is poised for significant growth and impact in the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $10.00M | 1 | MVM Life Science Partners | 03 Jan 2013 |
No recent news or press coverage available for eZono AG.